Increasingly, Japanese pharmaceutical companies are expanding their activities into the United States, Europe and other markets. At the same time, more and more multinationals are discovering the potential of the Japanese market. Quintiles Japan is here to serve such companies including those without presence in Japan as well as Japanese pharmaceutical companies.

Click here to learn how Quintiles is connecting insights with superior delivery for better outcomes – all to make your goals a reality.

Click here to listen how multinational companies without a local presence can improve their probability of success in Japan.

Click here to learn how Quintiles Japan can help you develop untapped local market potential.

Click here to learn how local partnering with Quintiles Japan can open global opportunities.

With seven facilities in Japan, Quintiles Japan provide fully integrated services for Phase I – IV clinical studies and a range of Commercial Services, developing the special expertise to help you achieve your goals:

In-country drug development.

Accelerated Japanese approvals through offshore trials.

Services for Japanese companies selling into Europe, the US and other markets.